Thermo Fisher Scientific (TMO) DIvidends Date & History

Key Takeaways

• Thermo Fisher Scientific offers a modest current dividend yield of approximately 0.33%, reflecting its focus on growth investments.
• The company pays a quarterly dividend of $0.47 per share, recently increased from $0.43, with the next payment scheduled for April 15, 2026.
• Payout ratio stands at a low 9.7%, indicating strong sustainability and room for future increases.
• Consistent dividend growth over the past decade, with annual raises nearly every year since 2014.
• Supported by robust free cash flow (FCF) of $6.3 billion TTM, easily covering dividend obligations.
• Higher yield than many life sciences peers, where industry median is near 0%.

Dividend Overview

Thermo Fisher Scientific (TMO), a leader in life sciences and analytical instruments, maintains a modest dividend policy suited to its growth-oriented profile. The current quarterly dividend is $0.47 per share, equating to an annualized payout of about $1.88 and a yield of roughly 0.33% based on recent stock prices. Payments occur quarterly, with the most recent ex-dividend date on March 13, 2026, and payment on April 15, 2026. This positions TMO as a dividend growth stock rather than a high-yield play, prioritizing reinvestment in R&D and acquisitions while providing reliable, increasing payouts to shareholders.

Dividend History and Growth

Thermo Fisher Scientific has demonstrated consistent dividend growth for over a decade. Quarterly payouts have risen steadily from $0.15 per share in 2014 to the current $0.47 in 2026, reflecting annual increases in most years. Key milestones include jumps from $0.26 in 2021 to $0.30 in 2022, $0.35 in 2023, $0.39 in 2024, $0.43 in 2025, and now $0.47 announced in February 2026. No cuts have occurred in recent history, underscoring a long-term strategy of returning capital via growing dividends alongside share repurchases. This track record highlights management's commitment to shareholder returns amid strong operational performance.

Dividend Sustainability and Payout Ratio

The dividend's sustainability is robust, with a payout ratio of just 9.7%, meaning only a fraction of earnings is distributed as dividends, leaving ample room for growth and reinvestment. Earnings comfortably cover the payout, supplemented by trailing twelve-month free cash flow (FCF) of $6.3 billion and operating cash flow of $7.8 billion—far exceeding the roughly $700 million annual dividend obligation. Moderate debt levels and a solid balance sheet further support ongoing payments. This conservative approach minimizes risk, positioning the dividend as highly secure even in economic downturns.

Dividend Compared to Industry Peers

In the life sciences tools and services industry, TMO's 0.33% yield exceeds the sector median of near 0%, appealing to investors seeking income in a growth-heavy field. Peers like Revvity (RVTY) offer 0.30%, while Danaher (DHR) and Agilent Technologies (A) provide similar low-single-digit yields around 0.4%-0.5%. Many competitors, such as Illumina, pay no dividend, emphasizing TMO's edge for income-focused investors in this innovative sector.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It excels at identifying dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to streamline your research today.

Is This Stock Attractive for Dividend Investors?

Thermo Fisher Scientific (TMO) suits dividend growth investors who prioritize steady increases over high current yields, given its consistent raises and low payout ratio. Long-term holders in the healthcare and life sciences sectors may appreciate the reliable quarterly payouts backed by dominant market position and innovation pipeline. Conservative investors could find appeal in the ultra-low payout ratio and massive FCF coverage, offering resilience during volatility. However, those seeking substantial income (e.g., 3%+ yields) may look elsewhere, as TMO channels most cash into growth initiatives like acquisitions and R&D. Balanced portfolios blending growth and modest income might include it for diversification, but yield chasers should temper expectations. Overall, it fits patient investors valuing capital appreciation with supplemental dividends.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations